GlassScriptPhysician profile
Christopher L Ahlering
NPI 1760419485
$2,305.45
in general payments reported to CMS, 2019-2025
28 companies · $401 in 2025
The $401 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $139 · 2021: $304 · 2022: $429 · 2023: $359 · 2024: $350 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,110.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.20 | 2019-2022 | |
| Astellas Pharma US INC | $231.88 | 2019-2025 | Veozah |
| Amgen INC. | $225.49 | 2019-2024 | Prolia, Evenity |
| Sumitomo Pharma America, INC. | $192.76 | 2023-2025 | Myfembree |
| Allergan, INC. | $151.06 | 2019 | |
| Evofem Biosciences, INC. | $122.92 | 2021-2025 | Solosec, Phexx, Phexxi |
| Exeltis, USA INC. | $104.73 | 2019-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $99.64 | 2020-2025 | |
| Meditrina | $92.07 | 2022-2025 | |
| Novo Nordisk INC | $89.16 | 2023-2025 | Wegovy |
| Pfizer INC. | $74.67 | 2019-2023 | |
| Ethicon US, LLC | $74.19 | 2022 | |
| Myovant Sciences INC. | $70.12 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $65.38 | 2025 | |
| Hologic Sales and Service, LLC | $61.60 | 2022-2024 | Aptima, Thinprep 2000 Processor, Third Wave |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $58.26 | 2024-2025 | Tymlos |
| Myriad Women'S Health, INC. | $51.63 | 2023 | Myrisk |
| Biohaven Pharmaceutical Holding Company LTD. | $51.29 | 2022 | |
| Avion Pharmaceuticals | $37.30 | 2020-2021 | |
| Lupin INC. | $34.49 | 2019-2021 | |
| Medtronic, INC. | $34.03 | 2022-2023 | Truclear |
| Aspira Women'S Health INC | $27.68 | 2021-2022 | |
| Sage Therapeutics, LLC | $22.24 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $16.02 | 2020 | |
| Merck Sharp & Dohme LLC | $15.65 | 2019 | |
| Minerva Surgical, INC | $15.01 | 2025 | |
| Monaghan Medical Corporation | $13.09 | 2023 | Aerobika |
| Agile Therapeutics, INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ahlering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.